For those that haven't, or haven't yet, researched LTP...

For those that haven't, or haven't yet, researched LTP it can easily seem as hype particularly as there are enough examples of that in the market to draw out the sceptics.

A closer look at LTP and maybe one will start to see there is more than hot air to the recent share price appreciation - things like:
- new verifiable treatment for ED eclipsing results of all products ever in market by a country mile (i.e. results within around 10mins instead of around 1hr) on lower dosage and lesser side effects due to superior delivery mechanism
- unlocking the ability to successfully achieve that superior delivery mechanism where others have tried, failed and probably given up (so LTP essentially has the secret sauce which cannot necessarily be replicated without the right drug and know-how which has taken years to crack)
- strong precedent of what is achievable in massive sales in a very short period for an approved first of a kind product (namely, Viagra) but now with all of the advantages mentioned above
- final results of recent (and very likely the last) study to be released within a few weeks which is expected to make global news
- upcoming meetings in 2024 with TGA and FDA ahead of, not for an investigational new drug or to move to yet another phase for safety or efficacy proofs, but for a new drug application (i.e. full approval to sell in AU and US respectively in 2025) remembering what happened with Viagra in terms of sales even in the first year upon full approval (again, now with all the advantages mentioned above)
- word on the street being that there is already strong demand from patients and clinics inundated with queries applicable to those who are able to be prescribed the treatment via the TGA pre approval scheme in AU with reports that results experienced in the real world are consistent with or better than those from the recent (and likely the last) trial
- above real world compelling data continuing to add to the good news story of the treatment ahead of full regulatory approval in 2025 for what is an easy to understand offering
- LTP's plans to ramp up prescriber network in the coming quarter for increased sales in AU under above mentioned pre approval scheme (which sales will still be pale in comparison to what sales can look like, and quickly, if full regulatory approval is received in 2025)
- expecting announcement of at least one other treatment for further indications to add to company assets and overall value
- results of ongoing partnering discussions if LTP is not sold altogether (and I expect not for a song with what are essentially founders holding a very large portion of the equity still currently in escrow with a good understanding of the underlying value, and not otherwise for easy pickings, with the limited free float)

Certainly difficult to predict moment by moment price action no matter how good a product or business is or can be, and we know that pullbacks are invariably a part of overall appreciation - you will see that every day of the working week in the best companies in the world. But in my opinion, these ought to be early days for LTP, and if the story plays out as early evidence seems to suggest it should, then there is a long way to go before one can in good conscience say that the share price has well and truly peaked. For me, despite all the early excitement we are seeing in this latter part of 2024, and which of course I don't mind especially given I was perplexed why this forum was so quiet even a few months ago, the real action will begin in 2025 with plenty happening between now and until then to keep things ticking in the right direction.

So if everything goes according to plan, I expect it won't be too long before every holder, today and in the near future, will be begging for one more opportunity to buy again at $1.80. Just like when I sat staring at my screen looking at opportunities to buy more at 40c not too long ago and at the same time noting to self (and on HC) of how annoyed I will be at myself in the future when I could have bought more at that price on that day but didn't. Accumulation of a decent holding has never been easy on this one given the limited free float, and what often feels like limited sellers, so one ends up paying a lot more lot sooner than expected after the conviction to commit finally settles in.